| Trial registration number
|
IRCT20210205050247N1 |
Full text link
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/54178
|
First author
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Abolfazl Taheri
|
Contact
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
dr.abolfazl.taheri@gmail.com
|
Registration date
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2021-02-13
|
Recruitment status
Last imported at : June 21, 2021, 1:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Long covid
|
Inclusion criteria
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Age between 20 and 65
No underlying disease including: hypertension, hypo and hyperthyroidism, seizures, diabetes, asthma, Bell's palsy
Continuation of olfactory reduction for more than two weeks
|
Exclusion criteria
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Patient dissatisfaction
Prolonged exposure to some chemicals agents (detergents)
History of head trauma
History of sinus surgery or septorhinoplasty, rhinoplasty, turbinectomy and radiation therapy
Having neurodegenerative disease (Alzheimer's, Parkinson, MS, epilepsy, seizures)
Having mental disorders (schizophrenia and depression)
Having neuropsychiatric disorders (autism, Asperger's, lack of concentration and hyperactivity)
History of repeated use of the following drugs:Metronidazole, benzocaine, clofibrate, amphotericin B, ampicillin, allopurinol, captopril, baclofen, codeine, carbamazepine and amphetamines.
|
Number of arms
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
3
|
Funding
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Bagheiat-allah University of Medical Sciences
|
Inclusion age min
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
20
|
Inclusion age max
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
65
|
Countries
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Patients recovered from covid
|
Severity scale
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
N/A
|
Total sample size
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
90
|
primary outcome
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Smell Identification
|
Notes
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 1
|
Arms
Last imported at : Feb. 16, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 920, "treatment_name": "Olfactory training or respiratory physiotherapy", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1656, "treatment_name": "Olfactory training+vitamin a", "treatment_type": "Olfactory training+vitamins and dietary supplements", "pharmacological_treatment": "Non pharmacological treatment+pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|